Table 2 The difference in median progression-free survival (PFS) is based on a given biomarker.
From: High WEE1 expression is independently linked to poor survival in multiple myeloma
Feature name | WEE1-high PFS (years) | WEE1-low PFS (years) |
---|---|---|
Hyperdiploidy | 1.838 | 2.685 |
t(4;14) | 1.115 | 2.436 |
t(11;14) | ND | 1.956 |
MAF translocation | ND | 1.921 |
MYC translocation | 2.121 | 2.436 |
Chromothripsis | 2.427 | 2.427 |
Hyper APOBEC | 2.378 | 1.942 |
TP53 deletion | ND | 1.608 |